Little Green Pharma (ASX:LGP) Gross Profit : A$19.14 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Little Green Pharma Gross Profit?

Little Green Pharma's gross profit for the six months ended in Sep. 2024 was A$11.24 Mil. Little Green Pharma's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was A$19.14 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Little Green Pharma's gross profit for the six months ended in Sep. 2024 was A$11.24 Mil. Little Green Pharma's Revenue for the six months ended in Sep. 2024 was A$17.51 Mil. Therefore, Little Green Pharma's Gross Margin % for the quarter that ended in Sep. 2024 was 64.19%.

Little Green Pharma had a gross margin of 64.19% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 5 years, the highest Gross Margin % of Little Green Pharma was 82.47%. The lowest was 51.18%. And the median was 56.76%.

Little Green Pharma Gross Profit Historical Data

The historical data trend for Little Green Pharma's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Little Green Pharma Gross Profit Chart

Little Green Pharma Annual Data

Trend

Jun19

Jun20

Jun21

Mar23

Mar24

Gross Profit

1.15

5.78

11.98

13.12

Little Green Pharma Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Mar23	Sep23	Mar24	Sep24
Gross Profit	Get a 7-Day Free Trial			4.39	-	5.22	7.90	11.24

Competitive Comparison of Little Green Pharma's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Little Green Pharma's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Gross Profit distribution charts can be found below:

* The bar in red indicates where Little Green Pharma's Gross Profit falls into.

Little Green Pharma Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Little Green Pharma's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )	=	Revenue	-	Cost of Goods Sold
	=	25.632	-	12.514
	=	13.12

Little Green Pharma's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )	=	Revenue	-	Cost of Goods Sold
	=	17.513	-	6.271
	=	11.24

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$19.14 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Little Green Pharma's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )	=	Gross Profit (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	11.24	/	17.513
	=	64.19 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Little Green Pharma (ASX:LGP) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Little Green Pharma had a gross margin of 64.19% for the quarter that ended in Sep. 2024 => Durable competitive advantage

Little Green Pharma Gross Profit Related Terms

Thank you for viewing the detailed overview of Little Green Pharma's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Little Green Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

N/A

Address

66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005

Website

https://www.littlegreenpharma.com

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma Headlines

No Headlines